14th International Congress of The Egyptian Society of Hepatology, Gastroenterology and Infectious Diseases in Alexandria (ESHGID 2012)

Abdel khalek H. Younes
Department of Dermatology , Andorology , and STDs
Al- Azhar university teaching hospitals –  Cairo – Egypt

Abstract 

Acknowledgements
I do respect to my patients for their cooperation during the process of the study

Background/Aims

Hepatitis C is an progressing global health problem. The expense of the exciting regimen for treatment is not available for many patients .Herbal medicine have been used as complementary therapy in the treatment of liver diseases for a long time. In the current study the herbal medicine used in treatment of HCV are Milk Thistle , Phyllanthus , Garlic  , Cinnamon , parsley ,  Black seed and AKHY-J-25 (mixture of herbs). The aims is to assess the efficacy of that complementary therapy in treating chronic hepatitis C.

Methods

Fifty one Patients with hepatitis C have been seen in our out  patient clinic , With Twelve healthy control . Patients were interviewed to obtain detailed clinical data before and after treatment. Every patient received single oral  capsule of herbal preparations powder , in early morning on an empty stomach with two cups of water and simple breakfast after two hours , from three months to two years and  twelve control received placebo.

Results

Twenty percent of patients had no detectable HCV RNA in serum at  24 week treatment ,72.6% showed clinical and  biochemical improvement with decline of PCR to lower limit  and 7.4% showed  clinical and  biochemical improvement  without change in level of  PCR. Mean PCR  , SGPT , SGOT , platelets , WBCS , neutrophils ,  Lymphocytes showed  very highly significant results (p=0.0001) , HG showed highly significant improvement(p=0. 001),Creatinine showed significant improvement ( p= 0.009 )  and Blood urea and RBS showed non significant changes respectively ( p =  23.98 , p = 2.2 ).

Conclusions

Traditional Egyptian herbal product showed significant improvement of hepatitis c.